Recommendations of diagnosis and treatment of primary Sj?gren′s syndrome in China
10.3760/cma.j.cn112138-20200113-00021
- VernacularTitle:原发性干燥综合征诊疗规范
- Author:
Wen ZHANG
1
;
Xiaomei LI
;
Dong XU
;
Dongzhou LIU
;
Jian XU
;
Futao ZHAO
;
Yan ZHAO
;
Xiaofeng ZENG
;
Yi DONG
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科 国家皮肤与免疫疾病临床医学研究中心 100730
- From:
Chinese Journal of Internal Medicine
2020;59(4):269-276
- CountryChina
- Language:Chinese
-
Abstract:
Sj?gren′s syndrome is a chronic systemic autoimmune disease characterized by lymphocyte proliferation and progressive exocrine gland damage. In China, standardized diagnosis and treatment for Sj?gren′s syndrome lags behind other common rheumatic diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Based on the evidence and guidelines from China and other countries, Chinese Sj?gren′s Syndrome Collaborative Research Group together with stomatologist and ophthalmologist developed Standardization of diagnosis and treatment of primary Sj?gren′s syndrome. The purposes are: (1) to standardize the detection and interpretation of key indicators for the diagnosis of Sj?gren's syndrome, including serum anti SSA antibody and labial gland pathology; (2) to suggest using widely accepted disease activity index in evaluation of the disease; (3) to standardize rational management for Sj?gren′s syndrome patients with topical and systemic diseases.
